Meeder Asset Management’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-9,035
| Closed | -$714 | – | 1806 |
|
|
2018
Q2 | $714 | Buy |
9,035
+5,382
| +147% | +$425 | ﹤0.01% | 1531 |
|
|
2018
Q1 | $1K | Buy |
3,653
+670
| +22% | +$183 | ﹤0.01% | 1531 |
|
|
2017
Q4 | $5K | Sell |
2,983
-1,107
| -27% | -$1.86K | ﹤0.01% | 1344 |
|
|
2017
Q3 | $6K | Buy |
4,090
+2,928
| +252% | +$4.3K | ﹤0.01% | 1244 |
|
|
2017
Q2 | $2K | Buy |
1,162
+604
| +108% | +$1.04K | ﹤0.01% | 1476 |
|
|
2017
Q1 | $2K | Sell |
558
-639
| -53% | -$2.29K | ﹤0.01% | 1463 |
|
|
2016
Q4 | $6K | Buy |
+1,197
| New | +$6K | ﹤0.01% | 847 |
|